Edgar T. Overton, MD

ViiV Healthcare
Durham, North Carolina, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1024 - Real-world Adherence and Persistence with Long-Acting Cabotegravir Plus Rilpivirine (CAB+RPV LA) Compared to Oral Antiretroviral Therapy (ART) Among People with HIV (PWH) in the US: The ABOVE Study

  Thursday, October 12, 2023
  3:27 PM – 3:39 PM US ET

• AE-52 - Real-World Evidence in HIV Treatment (Sponsored by ViiV Healthcare)

  Friday, October 13, 2023
  1:15 PM – 2:00 PM US ET